A novel atypical retinoid endowed with proapoptotic and antitumor activity

Raffaella Cincinelli, Sabrina Dallavalle, Lucio Merlini, Sergio Penco, Claudio Pisano, Paolo Carminati, Giuseppe Giannini, Loredana Vesci, Carlo Gaetano, Barbara Illy, Valentina Zuco, Rosanna Supino, Franco Zunino

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

The novel atypical retinoid E-3-(4′-hydroxy-3′-adamantylbiphenyl-4-yl)acrylic acid (ST1926, 4) exhibited a potent antiproliferative activity on a large panel of human tumor cells. Despite almost complete loss of ability to activate RARs, the compound was an effective apoptosis inducer and surprisingly produced DNA damage, that likely contributes to the proapoptotic activity. Following oral administration, 4 was well tolerated and caused tumor growth inhibition in the ovarian carcinoma, A2780/DX, and in the human melanoma, MeWo, growing in nude mice, thus supporting the therapeutic interest of the novel agent.

Original languageEnglish
Pages (from-to)909-912
Number of pages4
JournalJournal of Medicinal Chemistry
Volume46
Issue number6
DOIs
Publication statusPublished - Mar 13 2003

Fingerprint

Retinoids
Tumors
Nude Mice
DNA Damage
Oral Administration
Melanoma
Neoplasms
Cells
Apoptosis
Carcinoma
DNA
Growth
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid
Therapeutics

ASJC Scopus subject areas

  • Organic Chemistry

Cite this

Cincinelli, R., Dallavalle, S., Merlini, L., Penco, S., Pisano, C., Carminati, P., ... Zunino, F. (2003). A novel atypical retinoid endowed with proapoptotic and antitumor activity. Journal of Medicinal Chemistry, 46(6), 909-912. https://doi.org/10.1021/jm025593y

A novel atypical retinoid endowed with proapoptotic and antitumor activity. / Cincinelli, Raffaella; Dallavalle, Sabrina; Merlini, Lucio; Penco, Sergio; Pisano, Claudio; Carminati, Paolo; Giannini, Giuseppe; Vesci, Loredana; Gaetano, Carlo; Illy, Barbara; Zuco, Valentina; Supino, Rosanna; Zunino, Franco.

In: Journal of Medicinal Chemistry, Vol. 46, No. 6, 13.03.2003, p. 909-912.

Research output: Contribution to journalArticle

Cincinelli, R, Dallavalle, S, Merlini, L, Penco, S, Pisano, C, Carminati, P, Giannini, G, Vesci, L, Gaetano, C, Illy, B, Zuco, V, Supino, R & Zunino, F 2003, 'A novel atypical retinoid endowed with proapoptotic and antitumor activity', Journal of Medicinal Chemistry, vol. 46, no. 6, pp. 909-912. https://doi.org/10.1021/jm025593y
Cincinelli R, Dallavalle S, Merlini L, Penco S, Pisano C, Carminati P et al. A novel atypical retinoid endowed with proapoptotic and antitumor activity. Journal of Medicinal Chemistry. 2003 Mar 13;46(6):909-912. https://doi.org/10.1021/jm025593y
Cincinelli, Raffaella ; Dallavalle, Sabrina ; Merlini, Lucio ; Penco, Sergio ; Pisano, Claudio ; Carminati, Paolo ; Giannini, Giuseppe ; Vesci, Loredana ; Gaetano, Carlo ; Illy, Barbara ; Zuco, Valentina ; Supino, Rosanna ; Zunino, Franco. / A novel atypical retinoid endowed with proapoptotic and antitumor activity. In: Journal of Medicinal Chemistry. 2003 ; Vol. 46, No. 6. pp. 909-912.
@article{51462c9eb6ab4e2faa1c780d44ed7614,
title = "A novel atypical retinoid endowed with proapoptotic and antitumor activity",
abstract = "The novel atypical retinoid E-3-(4′-hydroxy-3′-adamantylbiphenyl-4-yl)acrylic acid (ST1926, 4) exhibited a potent antiproliferative activity on a large panel of human tumor cells. Despite almost complete loss of ability to activate RARs, the compound was an effective apoptosis inducer and surprisingly produced DNA damage, that likely contributes to the proapoptotic activity. Following oral administration, 4 was well tolerated and caused tumor growth inhibition in the ovarian carcinoma, A2780/DX, and in the human melanoma, MeWo, growing in nude mice, thus supporting the therapeutic interest of the novel agent.",
author = "Raffaella Cincinelli and Sabrina Dallavalle and Lucio Merlini and Sergio Penco and Claudio Pisano and Paolo Carminati and Giuseppe Giannini and Loredana Vesci and Carlo Gaetano and Barbara Illy and Valentina Zuco and Rosanna Supino and Franco Zunino",
year = "2003",
month = "3",
day = "13",
doi = "10.1021/jm025593y",
language = "English",
volume = "46",
pages = "909--912",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "6",

}

TY - JOUR

T1 - A novel atypical retinoid endowed with proapoptotic and antitumor activity

AU - Cincinelli, Raffaella

AU - Dallavalle, Sabrina

AU - Merlini, Lucio

AU - Penco, Sergio

AU - Pisano, Claudio

AU - Carminati, Paolo

AU - Giannini, Giuseppe

AU - Vesci, Loredana

AU - Gaetano, Carlo

AU - Illy, Barbara

AU - Zuco, Valentina

AU - Supino, Rosanna

AU - Zunino, Franco

PY - 2003/3/13

Y1 - 2003/3/13

N2 - The novel atypical retinoid E-3-(4′-hydroxy-3′-adamantylbiphenyl-4-yl)acrylic acid (ST1926, 4) exhibited a potent antiproliferative activity on a large panel of human tumor cells. Despite almost complete loss of ability to activate RARs, the compound was an effective apoptosis inducer and surprisingly produced DNA damage, that likely contributes to the proapoptotic activity. Following oral administration, 4 was well tolerated and caused tumor growth inhibition in the ovarian carcinoma, A2780/DX, and in the human melanoma, MeWo, growing in nude mice, thus supporting the therapeutic interest of the novel agent.

AB - The novel atypical retinoid E-3-(4′-hydroxy-3′-adamantylbiphenyl-4-yl)acrylic acid (ST1926, 4) exhibited a potent antiproliferative activity on a large panel of human tumor cells. Despite almost complete loss of ability to activate RARs, the compound was an effective apoptosis inducer and surprisingly produced DNA damage, that likely contributes to the proapoptotic activity. Following oral administration, 4 was well tolerated and caused tumor growth inhibition in the ovarian carcinoma, A2780/DX, and in the human melanoma, MeWo, growing in nude mice, thus supporting the therapeutic interest of the novel agent.

UR - http://www.scopus.com/inward/record.url?scp=0037435048&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037435048&partnerID=8YFLogxK

U2 - 10.1021/jm025593y

DO - 10.1021/jm025593y

M3 - Article

C2 - 12620066

AN - SCOPUS:0037435048

VL - 46

SP - 909

EP - 912

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 6

ER -